Thompson Street-backed Vector Laboratories to merge with Absolute Biotech.

Thompson Street-backed Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, agreed to merge with Absolute Biotech, a unified company of multiple antibody-centric brands. Financial terms were not disclosed. “The combination with Absolute Biotech will be a tremendous opportunity to better position Vector Laboratories as a strong partner to biopharma and life sciences companies. For pharma and biotech customers developing biotherapeutics, particularly antibody-drug conjugates, it’s important that their suppliers can also provide expert guidance in identifying the appropriate solutions to help them succeed,” Lisa V. Sellers, Vector Laboratories CEO.